Seizert Capital Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.4M | Sell |
120,839
-5,093
| -4% | -$1.67M | 1.63% | 29 |
|
|
2025
Q4 | $44.1M | Sell |
125,932
-1,894
| -1% | -$640K | 1.86% | 24 |
|
|
2025
Q3 | $41.3M | Sell |
127,826
-6,027
| -5% | -$1.87M | 1.79% | 28 |
|
|
2025
Q2 | $52.1M | Buy |
133,853
+77
| +0.1% | +$31K | 2.29% | 14 |
|
|
2025
Q1 | $58.2M | Buy |
133,776
+3,514
| +3% | +$1.41M | 2.67% | 7 |
|
|
2024
Q4 | $48.1M | Buy |
130,262
+26,033
| +25% | +$10.9M | 2.17% | 17 |
|
|
2024
Q3 | $54.2M | Buy |
104,229
+21,708
| +26% | +$11.6M | 2.45% | 9 |
|
|
2024
Q2 | $44.7M | Sell |
82,521
-4,627
| -5% | -$2.45M | 2.22% | 14 |
|
|
2024
Q1 | $45.2M | Buy |
87,148
+1,221
| +1% | +$607K | 2.08% | 16 |
|
|
2023
Q4 | $40.5M | Sell |
85,927
-148
| -0.2% | -$68.4K | 2.05% | 16 |
|
|
2023
Q3 | $37.5M | Buy |
86,075
+1,394
| +2% | +$632K | 1.99% | 17 |
|
|
2023
Q2 | $37.6M | Sell |
84,681
-170
| -0.2% | -$78.4K | 2.02% | 18 |
|
|
2023
Q1 | $39M | Sell |
84,851
-3,037
| -3% | -$1.45M | 2.15% | 14 |
|
|
2022
Q4 | $45.1M | Sell |
87,888
-132
| -0.1% | -$67K | 2.39% | 10 |
|
|
2022
Q3 | $40M | Buy |
88,020
+380
| +0.4% | +$182K | 2.25% | 11 |
|
|
2022
Q2 | $42.3M | Sell |
87,640
-12,631
| -13% | -$6.25M | 2.24% | 9 |
|
|
2022
Q1 | $49.3M | Sell |
100,271
-2,173
| -2% | -$993K | 2.26% | 11 |
|
|
2021
Q4 | $47.5M | Sell |
102,444
-2,921
| -3% | -$1.23M | 2.12% | 15 |
|
|
2021
Q3 | $39.3M | Buy |
105,365
+3,239
| +3% | +$1.23M | 1.8% | 20 |
|
|
2021
Q2 | $39M | Buy |
102,126
+2,863
| +3% | +$1.09M | 1.86% | 21 |
|
|
2021
Q1 | $35.6M | Buy |
99,263
+6,415
| +7% | +$2.06M | 1.86% | 17 |
|
|
2020
Q4 | $29.8M | Sell |
92,848
-3,869
| -4% | -$1.19M | 1.74% | 22 |
|
|
2020
Q3 | $26M | Buy |
96,717
+726
| +0.8% | +$195K | 1.71% | 29 |
|
|
2020
Q2 | $25.2M | Buy |
95,991
+15,083
| +19% | +$4.02M | 1.71% | 24 |
|
|
2020
Q1 | $18.4M | Sell |
80,908
-9,372
| -10% | -$2.55M | 1.35% | 34 |
|
|
2019
Q4 | $27.3M | Sell |
90,280
-3,877
| -4% | -$1.07M | 1.36% | 29 |
|
|
2019
Q3 | $22.6M | Sell |
94,157
-5,115
| -5% | -$1.4M | 1.14% | 34 |
|
|
2019
Q2 | $28M | Buy |
99,272
+12,390
| +14% | +$3.38M | 1.38% | 29 |
|
|
2019
Q1 | $24.9M | Sell |
86,882
-198
| -0.2% | -$57.3K | 1.12% | 39 |
|
|
2018
Q4 | $22.9M | Buy |
87,080
+2,853
| +3% | +$785K | 1.03% | 45 |
|
|
2018
Q3 | $23.1M | Sell |
84,227
-8,181
| -9% | -$2.12M | 0.85% | 50 |
|
|
2018
Q2 | $20.3M | Hold |
92,408
| – | – | 0.74% | 51 |
|
|
2018
Q1 | $20.3M | Sell |
92,408
-8,855
| -9% | -$2.08M | 0.74% | 51 |
|
|
2017
Q4 | $22.8M | Sell |
101,263
-20,354
| -17% | -$4.34M | 0.82% | 49 |
|
|
2017
Q3 | $23.1M | Buy |
121,617
+249
| +0.2% | +$47.4K | 0.85% | 47 |
|
|
2017
Q2 | $22.8M | Sell |
121,368
-1,257
| -1% | -$226K | 0.83% | 47 |
|
|
2017
Q1 | $20.3M | Sell |
122,625
-56,424
| -32% | -$8.98M | 0.72% | 52 |
|
|
2016
Q4 | $25.7M | Sell |
179,049
-29,151
| -14% | -$3.9M | 0.91% | 46 |
|
|
2016
Q3 | $26.1M | Buy |
208,200
+84,435
| +68% | +$10.9M | 0.97% | 42 |
|
|
2016
Q2 | $16.3M | Sell |
123,765
-2,248
| -2% | -$308K | 0.62% | 56 |
|
|
2016
Q1 | $17.5M | Sell |
126,013
-10,038
| -7% | -$1.34M | 0.6% | 56 |
|
|
2015
Q4 | $19M | Buy |
136,051
+14,692
| +12% | +$2.02M | 0.59% | 56 |
|
|
2015
Q3 | $17M | Buy |
121,359
+3,460
| +3% | +$520K | 0.51% | 60 |
|
|
2015
Q2 | $19.4M | Sell |
117,899
-49,151
| -29% | -$7.85M | 0.49% | 64 |
|
|
2015
Q1 | $25.8M | Sell |
167,050
-151,823
| -48% | -$21.6M | 0.65% | 58 |
|
|
2014
Q4 | $40.1M | Sell |
318,873
-12,119
| -4% | -$1.5M | 0.85% | 54 |
|
|
2014
Q3 | $39.6M | Sell |
330,992
-5,553
| -2% | -$637K | 0.79% | 55 |
|
|
2014
Q2 | $36.2M | Buy |
336,545
+8,615
| +3% | +$888K | 0.72% | 55 |
|
|
2014
Q1 | $32.6M | Sell |
327,930
-1,485
| -0.5% | -$134K | 0.76% | 57 |
|
|
2013
Q4 | $30.4M | Buy |
329,415
+32,623
| +11% | +$2.9M | 0.72% | 57 |
|
|
2013
Q3 | $24.8M | Buy |
+296,792
| New | +$25.4M | 0.68% | 58 |
|
Other funds holding ELV
VCM
VPM
Seizert Capital Partners's ELV Position: Q1 2026 in Review
Seizert Capital Partners reduced its Elevance Health (ELV) stake by 4% in Q1 2026, selling an estimated $1.67M and leaving 120,839 shares worth $35.4M. The position accounts for 1.63% of the portfolio, ranked #29.
Seizert Capital Partners first reported a position in ELV in Q3 2013 and has held it in 51 quarters since. The position peaked at $58.2M in Q1 2025. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Seizert Capital Partners held 120,839 shares of Elevance Health worth $35.4M as of Q1 2026.
- Seizert Capital Partners sold 5,093 Elevance Health shares in Q1 2026, an estimated $1.67M.
- Elevance Health made up 1.63% of Seizert Capital Partners's portfolio in Q1 2026, its #29 holding.
- Seizert Capital Partners first reported a position in Elevance Health in Q3 2013 and has held it in 51 quarters since.
- Seizert Capital Partners's Elevance Health position peaked at $58.2M in Q1 2025.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Seizert Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.